Auriga Reiterates a 'Hold' on athenahealth (ATHN); UH Deal is Nice, but Maybe Too Much Hullabaloo

July 11, 2011 7:31 AM EDT
Get Alerts ATHN Hot Sheet
Price: $9.59 --0%

Rating Summary:
    6 Buy, 22 Hold, 2 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Auriga reiterates a 'Hold' on athenahealth (NASDAQ: ATHN), PT $45.

Auriga analyst says, "We are reiterating our HOLD rating on athenahealth on the heels of last week's contract expansion with University Hospitals (UH) and in advance of earnings on July 21. While the contract represents a nice enterprise win at a meaningful customer, we caution that some level of enterprise deals (in addition to cross-selling) will likely be a must-have, rather than a nice-to-have to maintain the company's 30% top-line growth targets. As such, we believe the stock's 11% move last week (if based on this one announcement), is overly enthusiastic, particularly considering the Company reports next week and our $0.17 estimate is $0.02 below consensus. Our preference is to wait for better opportunities to buy the name."

For more ratings news on athenahealth click here and for the rating history of athenahealth click here.

Shares of athenahealth closed at $46.93 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments

Related Entities

Auriga, Earnings